On August 30, 2023 Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, reported that it will webcast its presentations at five investor conferences in September. The presentations will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer, and Nate Hardy, Sana’s Chief Financial Officer (Press release, Sana Biotechnology, AUG 30, 2023, View Source [SID1234634778]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Steve Harr will present at Citi’s 18th Annual BioPharma Conference at 10:30 a.m. ET on Wednesday, September 6, 2023.
Steve Harr will present at the 2023 Wells Fargo Healthcare Conference at 2:15 p.m. ET on Thursday, September 7, 2023.
Nate Hardy will present at the HC Wainwright 25th Annual Global Investment Conference at 10:00 a.m. ET on Monday, September 11, 2023.
Steve Harr will present at the Morgan Stanley 21st Annual Healthcare Conference at 1:35 p.m. ET on Tuesday, September 12, 2023.
Nate Hardy will present at the 2023 Cantor Global Healthcare Conference at 10:55 a.m. ET on Wednesday, September 27, 2023.
The webcasts will be accessible on the Investor Relations page of Sana’s website at View Source A replay of each presentation will be available at the same location for 30 days following the corresponding conference.

On August 30, 2023 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported that Raul Rodriguez, the company’s president and chief executive officer, and Dean Schorno, the company’s chief financial officer, will participate in the following investor conferences in September (Press release, Rigel, AUG 30, 2023, View Source [SID1234634777]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2023 Wells Fargo Healthcare Conference, September 6-8, 2023, Boston, MA
Raul Rodriguez will present a company overview on Wednesday, September 6th at 12:45 p.m. ET.

Citi’s 18th Annual BioPharma Conference, September 6-7, 2023, Boston, MA
Rigel management will participate in one-on-one meetings on Thursday, September 7th.

To access the live webcast of the Wells Fargo Healthcare Conference presentation, visit the Investor Relations section of the company’s website at www.rigel.com. Please connect to Rigel’s website prior to the start of the live webcast to allow for any software downloads.

On August 30, 2023 RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, reported that members of the RAPT management team will participate in the following investor conferences in September (Press release, RAPT Therapeutics, AUG 30, 2023, https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-participate-several-upcoming-investor-2 [SID1234634776]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2023 Healthcare Conference – Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET

H.C. Wainwright 25th Annual Global Investment Conference – Presentation on Monday, September 11, 2023 at 2:00 p.m. ET

Stifel 2023 Immunology and Inflammation Virtual Summit – Fireside chat on Tuesday, September 19, 2023 at 3:45 p.m. ET

Cantor Global Healthcare Conference – Presentation on Tuesday, September 26, 2023 at 10:35 a.m. ET
To access the available live webcasts or subsequent archived recordings of the discussions and presentations, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

On August 30, 2023 PTC Therapeutics, Inc. (NASDAQ: PTCT) reported that the company will present a company overview at the following conferences (Press release, PTC Therapeutics, AUG 30, 2023, View Source [SID1234634775]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 2023 18th Annual BioPharma Conference
Wednesday, Sept. 6, at 9:40 a.m. EDT

Morgan Stanley 21st Annual Global Healthcare Conference 2023
Monday, Sept. 11, at 1:35 p.m. EDT

2023 Cantor Global Healthcare Conference
Tuesday, Sept. 26, at 12:25 p.m. EDT

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics’ website at View Source and will be archived for 30 days following the presentation. It is recommended that users connect to PTC’s website several minutes prior to the start of the webcast to ensure a timely connection.

On August 30, 2023 ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, reported that management will participate in the following investor conferences in the first half of September (Press release, ORIC Pharmaceuticals, AUG 30, 2023, View Source [SID1234634774]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2023 18th Annual BioPharma Conference – Participating in a targeted oncology panel on Wednesday, September 6, 2023, at 1:00 p.m. ET

Wells Fargo 2023 Healthcare Conference – Participating in a fireside chat on Thursday, September 7, 2023, at 11:00 a.m. ET

H.C. Wainwright 25th Annual Global Investment Conference – Presenting company overview on Monday, September 11, 2023, at 12:30 p.m. ET

Baird 2023 Global Healthcare Conference – Participating in a fireside chat on Tuesday, September 12, 2023, at 2:35 p.m. ET
Webcasts of the panel discussion and presentations will be available through the investor section of the company’s website at www.oricpharma.com. Replays of webcasts will be available for 90 days following the events.